Ehsan Sharifipour

1.7k total citations · 1 hit paper
49 papers, 849 citations indexed

About

Ehsan Sharifipour is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ehsan Sharifipour has authored 49 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Neurology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ehsan Sharifipour's work include Acute Ischemic Stroke Management (15 papers), Stroke Rehabilitation and Recovery (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Ehsan Sharifipour is often cited by papers focused on Acute Ischemic Stroke Management (15 papers), Stroke Rehabilitation and Recovery (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Ehsan Sharifipour collaborates with scholars based in Iran, Denmark and United States. Ehsan Sharifipour's co-authors include Alireza Koohpaei, Samad EJ Golzari, Saeed Shams, Javad Khodadadi, Reza Fotouhi-Ardakani, Zahra Doosti, Elyar Sadeghi‐Hokmabadi, Reza Rikhtegar, Masoud Nikanfar and Mazyar Hashemilar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the Neurological Sciences and International Immunopharmacology.

In The Last Decade

Ehsan Sharifipour

47 papers receiving 832 citations

Hit Papers

Evaluation of bacterial co-infections of the respiratory ... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Sharifipour Iran 16 210 168 158 140 101 49 849
Alberto Corona Italy 18 231 1.1× 95 0.6× 257 1.6× 149 1.1× 98 1.0× 58 1.1k
Kajal Jain India 19 183 0.9× 162 1.0× 65 0.4× 36 0.3× 101 1.0× 126 1.2k
Figen Esen Türkiye 21 322 1.5× 131 0.8× 147 0.9× 32 0.2× 345 3.4× 78 1.2k
Anwarul Haque Pakistan 18 205 1.0× 21 0.1× 90 0.6× 37 0.3× 230 2.3× 68 1.0k
Ruth B. Veenhuizen Netherlands 16 296 1.4× 55 0.3× 113 0.7× 237 1.7× 191 1.9× 36 822
F. Gilsanz Spain 18 174 0.8× 98 0.6× 62 0.4× 47 0.3× 106 1.0× 146 1.1k
Raúl Méndez Spain 21 525 2.5× 159 0.9× 191 1.2× 17 0.1× 436 4.3× 68 1.3k
Martin Risch Switzerland 24 176 0.8× 111 0.7× 38 0.2× 15 0.1× 135 1.3× 97 1.4k
Amit Frenkel Israel 15 224 1.1× 56 0.3× 72 0.5× 12 0.1× 127 1.3× 71 768
Edoardo Picetti Italy 19 204 1.0× 177 1.1× 374 2.4× 14 0.1× 213 2.1× 55 1.0k

Countries citing papers authored by Ehsan Sharifipour

Since Specialization
Citations

This map shows the geographic impact of Ehsan Sharifipour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Sharifipour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Sharifipour more than expected).

Fields of papers citing papers by Ehsan Sharifipour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Sharifipour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Sharifipour. The network helps show where Ehsan Sharifipour may publish in the future.

Co-authorship network of co-authors of Ehsan Sharifipour

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Sharifipour. A scholar is included among the top collaborators of Ehsan Sharifipour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Sharifipour. Ehsan Sharifipour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ahmadpour, Sajjad, et al.. (2023). Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment ofResistant Subacute and Chronic Cough: A Pilot Clinical Trials Study. Reviews on Recent Clinical Trials. 18(4). 269–274. 4 indexed citations
4.
Sahraian, Mohammad Ali, Fereshteh Ashtari, Seyed Mohammad Baghbanian, et al.. (2023). Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis. Archives of Iranian Medicine. 26(8). 413–418. 1 indexed citations
5.
Sharifipour, Ehsan, et al.. (2023). Cerebral hemodynamic response to generalized anxiety disorder. Psychiatry Research Neuroimaging. 333. 111654–111654. 1 indexed citations
6.
Farhoudi, Mehdi & Ehsan Sharifipour. (2022). Iranian stroke model-how to involve health policymakers. Pakistan Journal of Neurological Sciences. 17(2). 3 indexed citations
8.
Hashemilar, Mazyar, et al.. (2022). Cerebral border zone infarctions: An etiologic study. PubMed. 21(1). 1–6. 1 indexed citations
9.
Salimi, Yazdan, Isaac Shiri, Azadeh Akhavanallaf, et al.. (2021). Deep learning-based fully automated Z-axis coverage range definition from scout scans to eliminate overscanning in chest CT imaging. Insights into Imaging. 12(1). 162–162. 37 indexed citations
10.
Vahedian, Mostafa, et al.. (2021). Effect of pre-hospital notification on delays and neurological outcomes in acute ischemic stroke. Australasian Emergency Care. 25(2). 172–175. 5 indexed citations
11.
Abbasinia, Mohammad, et al.. (2021). Nurses’ experiences of providing ethical care to the patients with COVID-19: A phenomenological study. Ethics Medicine and Public Health. 22. 100717–100717. 9 indexed citations
12.
Sharifipour, Ehsan, Saeed Shams, Javad Khodadadi, et al.. (2020). Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infectious Diseases. 20(1). 646–646. 268 indexed citations breakdown →
13.
Malekzadeh, Reza, Atefeh Abedini, Ehsan Sharifipour, et al.. (2020). Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. 89(Pt B). 107102–107102. 25 indexed citations
14.
Sharifipour, Ehsan, et al.. (2019). Altered plasma visfatin levels and insulin resistance in patients with Alzheimer’s disease. Acta Neurologica Belgica. 120(4). 901–906. 7 indexed citations
15.
Sharifipour, Ehsan, et al.. (2018). Efficacy of carotid artery stenting on stroke prevention of octogenarians. Clinical Neurology and Neurosurgery. 173. 187–193. 2 indexed citations
16.
Hejazi, Seyed Amir, et al.. (2018). Cognitive Impairment in Patients with Coronary Artery Disease; Comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). Journal of Advances in Medical and Biomedical Research. 26(119). 12–16. 4 indexed citations
17.
Sharifipour, Ehsan, et al.. (2016). Deletion of region of difference 181 in Mycobacterium tuberculosis Beijing strains. International Journal of Mycobacteriology. 5. S238–S239. 2 indexed citations
18.
Sadeghi‐Hokmabadi, Elyar, et al.. (2016). Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study. International Journal of General Medicine. Volume 9. 361–367. 9 indexed citations
19.
Ayromlou, Hormoz, Hassan Soleimanpour, Mehdi Farhoudi, et al.. (2014). Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation. Iranian Red Crescent Medical Journal. 16(5). e11284–e11284. 19 indexed citations
20.
Talebi, Mahnaz, et al.. (2013). Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.. PubMed. 12(3). 81–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026